In Ewing sarcoma, HDAC6 modulates acetylation of SP1 and its binding to activating promoter regions [44], and a reduction in SP1 acetylation was shown to result in loss of promoter binding associated with cell cycle arrest in colon cancer [45]. Here, HDAC6 is linked to malignant colon neoplasm.